Sygnature Discovery Limited
Louise Birch is an experienced computational chemist with a robust background in drug design and development. Currently serving as Associate Director at Sygnature Discovery since August 2014, Louise has previously held senior scientist roles at BioFocus and Eisai, where significant contributions included establishing a computational chemistry group and delivering successful CADD solutions for neuroscience projects. Louise also brought expertise in structure-based drug design during tenures at De Novo Pharmaceuticals. Academic qualifications include a PhD in Chemistry and an MSci in Natural Sciences, both from the University of Cambridge.
This person is not in the org chart
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.